Go To Global Site
Welcome to UCB in the United States

Jun

12

Press Release: First Presentations of Bimekizumab Phase 3 Data Demonstrate Superior Skin Clearance Over Placebo and Stelara at Week 16 in Adults with Moderate-to-Severe Plaque Psoriasis

• Data from the Phase 3 BE VIVID and BE READY studies show that bimekizumab-treated patients with psoriasis achieved significant skin clearance at week 16, rapid response after one dose, and durability of response up to a year
• Results support the importance of selectively inhibiting IL-17F, in addition to IL-17A, with bimekizumab

Jun

11

Empowering Patients Impacted by Immuno-Dermatological Conditions

At UCB, everything we do starts with one simple question: “How will this make a difference in the lives of people living with severe diseases?” This question is our motivation, inspiration and what challenges us to stay focused on what will ultimately benefit the patients we serve. Read more from Camille Lee, Head of U.S. Immunology, about how UCB is working to empower patients impacted by immuno-dermatological conditions.

Jun

05

Press Release: UCB acquires Engage Therapeutics: Staccato Alprazolam - A potential solution for acute on-demand seizure management for people living with epilepsy

• Underlines UCB’s leadership in epilepsy by adding Staccato® Alprazolam, a drug-device-combination with the potential to be the first on-demand, single-use treatment to rapidly terminate an active epileptic seizure

May

29

Andrea Loewendorf and Jessica Williamson Recognized as 2020 HBA Rising Stars

Congratulations to Andrea Loewendorf – Head, Market Access and Innovation Strategy, Neurology and Jessica Williamson, PhD – Protein Production Lead for their recognition as a Healthcare Businesswomen's Association (HBA) Rising Stars for 2020!

UCB Alison Headshot Blog

May

20

UCB's Collaborative Approach to Improving Patient Care and Outcomes in Osteoporosis

At UCB, we are using our passion and expertise to address gaps in post-fracture care to provide patients the support they need. This Osteoporosis Awareness Month, read from Alison Kocanda, Head of U.S. Bone, as she shares how UCB is supporting patients through education and resources.

May

18

Bridging the Gaps in Osteoporosis

Every three seconds - that is how often it is estimated that a fragility fracture occurs. Although nearly 9 million fractures occur annually worldwide, oftentimes people think fragile bones are an inevitable part of getting older, but a fracture may more commonly be the result of an underlying condition: osteoporosis. This May for Osteoporosis Awareness Month, we’re highlighting things to know about osteoporosis and our commitment to addressing the gaps impacting those living with the disease.

May

15

UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

May

12

Recognizing the Many Forms of Arthritis this Arthritis Awareness Month

UCB is passionate about transforming the lives of people living with severe diseases and uncovering the intersections of scientific understanding and patient needs. This May, we are honoring Arthritis Awareness Month and Spondyloarthritis Awareness Month by exploring the impacts of different kinds of arthritis on patients. Learn more about psoriatic arthritis, rheumatoid arthritis, and non-radiographic axial spondyloarthritis, their prevalence, and how individuals living with these diseases are impacted.

May

08

Disease Spotlight: Psoriatic Arthritis

Developing impactful and innovative solutions for patients whose lives have been challenged by severe diseases is our focus at UCB. This Arthritis Awareness Month, learn more about psoriatic arthritis (PsA), one of the many types of arthritic disease.

Apr

24

UCB Volunteers Help Communities Impacted by COVID-19

Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.